Federated Hermes’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Federated Hermes’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-37,070	Closed	-$6.41M	–	2183
2015 Q1	$6.41M	Sell	37,070 -564,285	-94%	-$82.8M	0.02%	546
2014 Q4	$69.1M	Sell	601,355 -605,202	-50%	-$73.3M	0.21%	93
2014 Q3	$189M	Sell	1,206,557 -7,337	-0.6%	-$1.06M	0.61%	29
2014 Q2	$150M	Sell	1,213,894 -215,278	-15%	-$23.8M	0.47%	40
2014 Q1	$148M	Sell	1,429,172 -377,805	-21%	-$38.7M	0.49%	39
2013 Q4	$163M	Sell	1,806,977 -10,304	-0.6%	-$822K	0.56%	35
2013 Q3	$122M	Sell	1,817,281 -402,819	-18%	-$27.8M	0.47%	44
2013 Q2	$147M	Buy	+2,220,100	New	+$127M	0.58%	38

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Federated Hermes's SLXP Position: Q2 2015 in Review

Federated Hermes sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 37,070 shares — an estimated $6.41M sold.

Federated Hermes first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $189M in Q3 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Federated Hermes reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Federated Hermes sold 37,070 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $6.41M.
Federated Hermes first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Federated Hermes's SALIX PHARMACEUTICALS LTD DEL position peaked at $189M in Q3 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Federated Hermes's 13F filing for Q2 2015, filed 12 Aug 2015.